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Nicotine is a type of environmental pollutant present in the tobacco waste that is
generated during tobacco manufacturing. Sphingomonas melonis TY can utilize nicotine
as a sole source of carbon, nitrogen and energy via a variant of the pyridine and
pyrrolidine pathway (the VPP pathway). In this study, we report the identification of two
novel sets of genes, ndrA1A2A3, and ndrB1B2B3B4, which are crucial for nicotine
degradation by strain TY. ndrA1A2A3 and ndrB1B2B3B4 exhibit similarity with both
nicotine dehydrogenase ndh from Arthrobacter nicotinovorans and nicotine hydroxylase
vppA from Ochrobactrum sp. SJY1. The transcriptional levels of ndrA1A2A3 and
ndrB1B2B3B4 in strain TY were significantly upregulated in the presence of nicotine.
Furthermore, ndrA1 or ndrB2 knockout resulted in a loss of the ability to degrade nicotine,
whereas gene complementation restored the capacity of each mutant to utilize nicotine
for growth. Biodegradation assays indicated that the mutant strains retained the ability
to degrade the first intermediate in the pathway, 6-hydroxynicotine (6 HN). However,
heterologous expression of ndrA1A2A3 and ndrB1B2B3B4 did not confer nicotine
dehydrogenase activity to E. coli DH5α, Pseudomonas putida KT2440 or Sphingomonas
aquatilis. These results provide information on the VPP pathway of nicotine degradation
in S. melonis TY, and we conclude that these two sets of genes have essential functions
in the conversion of nicotine to 6 HN in strain TY.
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INTRODUCTION
Tobacco products are among the most widely popular goods worldwide due to the addictive
component in tobacco: nicotine. Nicotine is the most abundant alkaloid in tobacco plants, and
a large amount of tobacco waste produced every year is disseminated in the environment through
water and soil. Nicotine is very harmful to public health because it can be easily absorbed and can
pass the blood-brain barrier (O’neill et al., 2002; Lemay et al., 2004).
As important decomposers in ecosystems, microbes possess powerful, and versatile degradation
capacities, as reflected in the type of substrates utilized, the metabolic mechanisms involved, and
diversity of catalyzing enzymes. One example is the diversity in metabolic pathways and molecular
mechanisms of nicotine degradation by microorganisms. Research on the microbial degradation
of nicotine has been studied since the 1950s (Wada and Yamasaki, 1953). To date, various bacteria
and fungi are reported to be able to decompose nicotine through at least six pathways, though
there are four main degradation pathways. (1) The pyridine pathway, which begins with the
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hydroxylation of the nicotine pyridine ring to generate
6-hydroxynicotine (6 HN), and then 6-hydroxy-N-
methylmyosmine, 6-hydroxypseudooxynicotine (6 HPON),
and 2, 6-dihydroxy-pseudooxynicotine, and generates nicotine
blue and succinic acid at last, has been described in Arthrobacter
(Hochstein and Rittenberg, 1959a,b, 1960; Richardson and
Rittenberg, 1961a,b; Gherna et al., 1965; Holmes and Rittenberg,
1972; Holmes et al., 1972; Chiribau et al., 2006), Nocardioides
(Ganas et al., 2008) and Rhodococcus (Cobzaru et al., 2011). And
the most studied metabolic pathway of the pyridine pathway was
encoded by megaplasmid pAO1 of Arthrobacter nicotinovorans
(Brandsch, 2006), for which every enzyme involved has been
validated. (2) The pyrrolidine pathway, representative of
Pseudomonas, begins with oxidation of the pyrrolidine ring
to produce N-methylmyosmine, which leads to formation of
succinate and 2, 5-dihydroxypyridine (2, 5-DHP); the latter
then enters the maleamic acid pathway (Wang et al., 2007; Tang
et al., 2012). This pathway has been comprehensively studied
in Pseudomonas putida S16, and the final steps are catalyzed
sequentially by DHP dioxygenase (Hpo), NFM deformylase
(Nfo), maleamate amidase (Ami) and maleate isomerase (Iso)
to produce fumaric acid (Tang et al., 2012). (3) The methyl
pathway, which is found in some fungi such as Aspergillus and
Pellicularia, degrades nicotine via demethylation to nornicotine
(Uchida et al., 1983; Meng et al., 2010), while the pathway
has not been well-elucidated. (4) A variant of the pyridine
and pyrrolidine (VPP) pathway constitutes the fourth main
pathway of nicotine degradation. Occurring in several strains,
the newly identified VPP pathway first transforms nicotine
into 6 HPON through 6-hydroxy-L-nicotine and 6-hydroxy-N-
methylmyosmine via the pyridine pathway; the intermediates
then enter the pyrrolidine pathway followed by formation
of 6-hydroxy-3-succinoylpyridine and 2, 5-DHP. This VPP
pathway has been described in Agrobacterium tumefaciens
strain S33, Shinella sp. HZN7, and Ochrobactrum sp. strain
SJY1 (Wang et al., 2012; Ma et al., 2013; Yu et al., 2014).
Surprisingly, a newly isolated strain, Pusillimonas sp. T2, was
found to possess both the VPP pathway and a partial pyridine
pathway with 2, 6-dihydroxypyridine formation (Ma et al., 2014).
Many intermediates, such as 6-hydroxy-3-succinoylpyridine,
generated through these diverse nicotine metabolic pathways
can potentially be transformed into commercially valuable
compounds such as analogs of epibatidine (Wang et al.,
2005). In addition, the various nicotine metabolic pathways
indicate the diversity of the mechanisms responsible. Although
Sphingomonas melonis strain TY, isolated by our research team,
can degrade nicotine efficiently, the genes involved are unclear
and may differ from the genes described thus far (Wang et al.,
2011).
In this work, we studied the nicotine-degrading S. melonis
strain TY, a new bacterium able to degrade nicotine via the
VPP pathway. The draft genome sequence of S. melonis TY
was obtained using the Illumina approach. Sequence analysis
revealed two sets of putative nicotine metabolic genes that




(S)–(-)-Nicotine (>99%) was obtained from Chemsky
international Co., Ltd (Shanghai, China). 6 HN was a gift from
Jiguo Qiu (Nanjing Agricultural University, China). TransStart R©
FastPfu DNA Polymerase for fragment amplification was
purchased from TransGen Biotech (Beijing, China). Restriction
enzymes used for plasmid construction and a premixed protein
marker for protein electrophoresis were purchased from Takara
Biotechnology Co., Ltd. (Dalian, China). Antibiotics, isopropyl
β-D-1-thiogalactopyranoside (IPTG) and other reagents were
purchased from Shanghai Sangon Biotech Co., Ltd. (Shanghai,
China). A plasmid extraction kit, gel extraction kit and DNA
purification kit were obtained from Omega Bio-tek, Inc
(Norcross, GA, USA).
PCR Programs Used in this Study
PCR program used for high-fidelity DNA polymerase was
according to the manual: pre-denaturing at 95◦C for 2min;
denaturing at 95◦C for 20 s, annealing at certain temperature
(according to the primer pair) for 20 s, extending at 72◦C at a
speed of 2 kb/min, 32 cycles; extending at 72◦C for 5min; keeping
at 4◦C. General PCR program used for fragment amplification
was pre-denaturing at 94◦C for 5min; denaturing at 94◦C for
30 s, annealing at certain temperature (according to the primer
pair) for 30 s, extending at 72◦C at a speed of 1 kb/min, 32 cycles;
extending at 72◦C for 5min, keeping at 4◦C. PCR program used
for reverse transcription quantitative PCR (RT-qPCR) was: pre-
denaturing at 94◦C for 30 s; denaturing at 94◦C for 5 s, annealing
at 60◦C for 15 s, extending at 72◦C for 12 s, 40 cycles.
Bacterial Strains, Plasmids, and Growth
Conditions
The bacterial strains and plasmids used in this study are listed
in Table 1; the primers used are provided in Table S1. Wild-
type S. melonis TY (collection number CGMCC 1.15791) can
utilize nicotine as a sole source of carbon, nitrogen and energy
for growth (Wang et al., 2011). Wild-type TY and derivatives
were cultured aerobically at 30◦C in LB medium or inorganic
salt medium (ISM) supplemented with nicotine, as described
previously (Yang, 2010). Escherichia coli strains were grown in LB
broth at 37◦C.When necessary, kanamycin and tetracycline were
used at final concentrations of 50 and 10µg/mL, respectively.
IPTG was used to induce expression at gradient concentration,
and 2, 6-diaminopimelic acid (2, 6-DAP) was used at a final
concentration of 0.3mM for E. coliWM3064.
Draft Genome Sequencing of S. melonis TY
and Prediction of Relevant Nicotine
Metabolism Genes
The draft genome sequence of S. melonis TY was obtained
using Illumina Hiseq2000 paired-end (PE) sequencing (101
bp for each read; 299.8-fold coverage) and then assembled
into 68 scaffolds using SOAPdenovo version 2.04 (N50 length,
205,244 bp) (Li et al., 2010). The draft genome sequence
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TABLE 1 | Strains and plasmids used in this study.
Strain or plasmid Relevant characteristics References or source
STRAINS
Escherichia coli
DH5α supE44 lacU169(Φ80dlacZ1M15)hsdR17 recA1 endA1 gyrA961thi relA1 Woodcock et al., 1989
DH5α pRK415
ndrB1B2B3B4orf1orf2
DH5α transformed with pRK415-ndrB1B2B3B4orf1orf2, TcR This study
DH5αpRK415 DH5α transformed with pRK415, TcR This study
WM3064 Donor strain for conjugation, 2,6-diaminopimelic acid auxotroph: thrB1004 pro thi rpsL hsdS lacZ1M15
RP4-1360 1(araBAD)567 1dapA1341::[erm pir(wt)]
Dehio and Meyer, 1997;
Saltikov and Newman,
2003




B )gal dcm lacY1(DE3) Transgen
BL21(DE3)pET28a-
ndrB1B2B3B4orf1orf2
BL21(DE3) transformed with pET28a-ndrB1B2B3B4orf1orf2, KanR This study
BL21(DE3)pET28a BL21(DE3) transformed with pET-28a(+), KanR This study
Sphingomonas SPECIES
TY Wild type, nicotine-degrading strain, G−, AmpR, KanS, TcS This study
TY1ndrA1 Sphingomonas melonis TY mutant with ndrA1 gene replaced by kanamycin resistance gene from
plasposon pTnMod-Okm, AmpR, KanR
This study
TY1ndrB2 Sphingomonas melonis TY mutant with ndrB2 gene replaced by kanamycin resistance gene from
plasposon pTnMod-Okm, AmpR, KanR
This study
TY1ndrA1(pRK415-ndrA1) ndrA1 gene was complemented by pRK415-ndrA1 in Sphingomonas melonis TY1ndrA1, AmpR, KanR,
TcR
This study
TY1ndrB2(pRK415-ndrB2) ndrB2 gene was complemented by pRK415-ndrB2 in Sphingomonas melonis TY1ndrB2, AmpR, KanR,
TcR
This study
Sphingomonas aquatilis Wild type, non-nicotine-degrading strain, G−, TcS Lee et al., 2001
A0463 pRK415ndrA1A2A3 Sphingomonas aquatilis transformed with pRK415-ndrA1A2A3, TcR This study
A0463 pRK415-ndrB1B2B3B4 Sphingomonas aquatilis transformed with pRK415-ndrB1B2B3B4, TcR This study
A0463
pRK415-ndrB1B2B3B4orf1orf2
Sphingomonas aquatilis transformed with pRK415-ndrB1B2B3B4orf1orf2, TcR This study
A0463pRK415 Sphingomonas aquatilis transformed with pRK415, TcR This study
Pseudomonas putida species
KT2440 Metabolically versatile saprophytic soil bacterium Nelson et al., 2002
KT2440 pRK415-ndrA1A2A3 KT2440 transformed with pRK415-ndrA1A2A3, TcR This study
KT2440pRK415-ndrB1B2B3B4 KT2440 transformed with pRK415- ndrB1B2B3B4, TcR This study
KT2440pRK415
ndrB1B2B3B4orf1orf2
KT2440 transformed with pRK415-ndrB1B2B3B4orf1orf2, TcR This study
KT2440pRK415 KT2440 transformed with pRK415, TcR This study
PLASMIDS
pTnMod-Okm Source of kanamycin resistance gene Dennis and Zylstra, 1998
pEX18Tc Gene knockout vector, oriT+, sacB+, TcR Hoang et al., 1998
pEX18Tc-ndrA1 ndrA1 gene knockout vector containing two DNA fragments homologous to the upstream and
downstream regions of the ndrA1 and kanamycin resistance gene from pTnMod-Okm
This study
pEX18Tc-ndrB2 ndrB2 gene knockout vector containing two DNA fragments homologous to the upstream and
downstream regions of the ndrB2 and kanamycin resistance gene from pTnMod-Okm
This study
pRK415 Broad host range vector, TcR Keen et al., 1988
pRK415-ndrA1 ndrA1 gene complementation vector by fusing ndrA1 into the Hind III-EcoR I restriction site of pRK415 This study
pRK415-ndrB2 ndrB2 gene complementation vector by fusing ndrB2 into the Hind III-EcoR I restriction site of pRK415 This study
pRK415-ndrA1A2A3 Heterologous expression vector with ndrA1A2A3 insert into the Hind III-EcoR I restriction site of pRK415 This study
pRK415-ndrB1B2B3B4 Heterologous expression vector with ndrB1B2B3B4 insert into the Hind III-EcoR I restriction site of
pRK415
This study
pRK415-ndrB1B2B3B4orf1orf2 Heterologous expression vector with ndrB1B2B3B4orf1orf2 insert into the Hind III-EcoR I restriction site
of pRK415
This study
pET-28a(+) Expression vector, KanR, C/N-terminal His·Tag/thrombin/T7·Tag, T7 lac promoter, T7 transcription start,
f1 origin, lacI
Novagen
pET28a-ndrB1B2B3B4orf1orf2 Expression vector for ndrB1B2B3B4orf1orf2 with C-terminal His·Tag by cloning ndrB1B2B3B4orf1orf2
into the Nco I-Hind III restriction site
This study
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of strain TY contains 4,100,783 bp with a GC content of
67.083% and 3748 predicted coding sequences (CDSs). The
annotation was performed using Best-placed reference protein
set; GeneMarkS+. Previously described nicotine-degrading
genes, including ndhLSM, which catalyzes the first step of
nicotine transformation in A. nicotinovorans (Dang Dai et al.,
1968; Grether-Beck et al., 1994), and vppA and vppB of the upper
VPP pathway of Ochrobactrum sp. SJY1 (Yu et al., 2014, 2015),
were used for blast searches of the strain TY genome in NCBI.
RT-qPCR Analysis of ndrA1A2A3 and
ndrB1B2B3B4
RNAprep Pure Bacteria Kit (Tiangen Biotech, Beijing, China)
was used to prepare total RNA from S. melonis TY grown
in triplicate in control and nicotine-induction cultures. The
RNA was reverse transcribed into cDNA using random hexamer
primers and PrimeScript RT Reagent Kit with gDNA Eraser
(Perfect Real Time) (Takara, Dalian, China). The respective
cDNA fragments were used as templates in PCR with gene-
specific primers (Table S1). Real-time quantitative PCR was
performed using a Rotor-Gene Q real-time PCR detection system
(Qiagen) with TransStart Top Green qPCR SuperMix (TransGen
Biotech, Beijing, China). The strain TY genome was used as the
positive control, and untranscribed RNAwas used as the negative
control. Melting curves and agarose gel analyses were applied
to confirm the specificity of the PCR products. The threshold
cycle (CT) values for each target gene were normalized to the
V3 region of the 16S rRNA gene. The 2−11CT method was
used to calculate the relative expression level, where 11CT =
(CT,target-CT,16S)induction—(CT,target-CT,16S)control; to obtain more
reliable results, the theoretical efficiency value 2 was replaced with
the estimated PCR efficiency value (Livak and Schmittgen, 2001;
Ramakers et al., 2003; Ruijter et al., 2009; Tuomi et al., 2010).
Gene Knockout and Complementation of
ndrA1 and ndrB2
In-frame disruption of ndrA1 and ndrB2 in strain S. melonis TY
was performed using the suicide plasmid pEX18Tc and a two-
step homologous recombination method as described previously
(Chen et al., 2014). Gene complementation were conducted the
same as described in Chen et al. (2014).
TY1ndrA1 and TY1ndrB2 Growth and
Resting Cell Reactions
Biotransformation tests were performed using wild-type TY
and derivative strains TY1ndrA1, TY1ndrA1(pRK415- ndrA1),
TY1ndrB2, and TY1ndrB2(pRK415-ndrB2) as well as an
inactivated wild-type TY strain [heated at 80◦C for 5min to
prevent nicotine absorption (Harwood et al., 1994)] and a control
consisting only of nicotine. The biotransformation test was
performed in a 150mL flask containing 60mg dry cell weight of
resting cells (approximately 5 OD600nm, with one OD600nm unit
equal to 0.40 g/L dry cell weight) and 0.5 g/L nicotine in 30 mL
of sterilized ISM medium; the culture was incubated at 30◦C and
200 rpm. Three sets of parallel experiments were performed for
each strain. Biotransformation tests using 6 HN were conducted
in a manner similar to nicotine that described above.
To test whether the two mutant strains retained the ability to
metabolize 6 HN, the first product formed in the VPP pathway,
strains TY1ndrA1, and TY1ndrB2were washed three times with
sterilized water and streaked onto ISM plates supplemented with
6 HN as the sole source carbon and nitrogen; the plates were
placed in an incubator (30◦C) for growth; wild-type TY was used
as a positive control.
Heterologous Expression of Two Sets of
Putative Nicotine-Degrading Genes
Nicotine catalysis activity of ndrA1A2A3 and ndrB1B2B3B4
was tested by heterologous expression. To test for nicotine
dehydrogenase activity using whole cell or crude cell extracts,
the two gene clusters were cloned (using primers shown in Table
S1) into the broad host-range cloning vector pRK415 (Hind
III- and EcoR I digested) and mated to P. putida KT2440 and
Sphingomonas aquatilis (two non-nicotine-degrading strains) via
E. coli WM3064. The culture conditions and enzyme activity
detection are those previously reported (Ganas and Brandsch,
2009), while the detection of production 6 HN was replaced by
UV-scan, and the host transformed with the control plasmid was
used as the negative control, wild-type TY set as positive control.
Genes orf2 (coding for glycosyl transferase) and orf1 (coding
for a XshC-Cox1-family protein) just downstream of ndrB4
exhibit similarity with mobA and coxF, respectively, which are
essential for nicotine dehydrogenase activity in A. nicotinovorans
pAO1 (Ganas and Brandsch, 2009) and may be required for
nicotine dehydrogenase cofactor synthesis in strain TY. We
cloned orf1 and orf2 together with ndrB1B2B3B4 into vector
pRK415 (Hind III- and EcoR I digested) according to a previous
report (Ganas and Brandsch, 2009), followed by transformation
of the plasmid into E. coli DH5α and mating to S. aquatilis and
P. putida KT2440 via E. coliWM3064. Moreover, we also cloned
these six genes into vector pET-28a(+) (Hind III- and Nco I-
digested) just downstream the T7 promoter and transformed
the plasmid into E. coli BL21(DE3) to induce expression with
various concentrations of IPTG (at 0, 0.1, 0.2, 0.5 and 1mM).
Activity tests were performed using whole cell and crude cell
extracts of the above recombinant strains and corresponding
negative controls with the host containing the original plasmid,
pRK415 or pET-28a(+). SDS-PAGE was carried out for the E.
coli BL21(DE3) derivative strains to detect induction under the
test conditions.
Genome Sequence Accession Number
This whole-genome shotgun project has been deposited at
DDBJ/ENA/GenBank under accession LQCK00000000. The
version described in this paper is version LQCK02000000.
RESULTS
Two Sets of Putative Nicotine
Dehydrogenase Genes in Strain TY
Genome sequencing can provide much information for research
into the functional mechanisms of microorganisms (Tang
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et al., 2013). The draft genome sequence of S. melonis TY was
obtained by Illumina sequencing, and blast searching of the
sequence using representative sequences for nicotine-degrading
enzymes from A. nicotinovorans and Ochrobactrum sp. SJY1
was performed. Based on gene similarity and organization,
we identified two sets of putative nicotine dehydrogenase
genes in TY: ndrA1A2A3 and ndrB1B2B3B4. According
to the annotation of genome sequence, ndrA1 encodes an
aldehyde dehydrogenase iron-sulfur subunit; ndrA2 encodes
a subunit of molybdopterin dehydrogenase; ndrA3 encodes
a subunit of xanthine dehydrogenase; ndrB1 encodes an
aldehyde dehydrogenase iron-sulfur subunit; ndrB2, ndrB3, and
ndrB4 all encode subunit of xanthine dehydrogenase. These
two sets of gene clusters, ndrA1A2A3 and ndrB1B2B3B4,
show similarity to the three subunits of ndh: nicotine
dehydrogenase subunit S (ndhS), nicotine dehydrogenase
subunit M (ndhM) and nicotine dehydrogenase subunit L
(ndhL). ndrA3, ndrB3, and ndrB4 show similarity to nicotine
hydroxylase subunit L (vppAL), and ndrA1 and ndrB1 show
similarity to nicotine hydroxylase subunit S (vppAS). All these
genes exhibit 15–44% amino acid sequence identity with
homologous nicotine-degrading proteins, with similar gene
organization. The gene organization and amino acid identity
shared with homologous genes ndh and vppA are shown in
Figure 1.
Transcriptional Levels of ndrA1A2A3 and
ndrB1B2B3B4 are Upregulated in the
Presence of Nicotine
To demonstrate a correlation between nicotine degradation
and the two sets of putative nicotine dehydrogenase genes,
the levels of mRNA expression of seven putative target genes
involved in nicotine degradation in S. melonis TY were estimated
using RT-qPCR and the 211CT method in the presence or
absence of nicotine. The V3 region of the 16S rRNA gene was
used as the reference. The results showed that transcription
of these genes was significantly upregulated in the presence of
nicotine compared to in its absence (Figure 2), suggesting that
transcription of ndrA1A2A3 and ndrB1B2B3B4 was induced by
nicotine.
The Identification and Characterization of
NdrA1A2A3 and NdrB1B2B3B4
To examine whether ndrA1A2A3 or ndrB1B2B3B4 is involved
in nicotine degradation in vivo, ndrA1 or ndrB2 was knocked
out via kanamycin resistance gene insertion using a gene
replacement technique based on homologous recombination.
Double crossover was verified by PCR (Figure 3) and sequencing
analysis. Although neither mutant strain, TY1ndrA1, or
TY1ndrB2, could grow on ISM containing nicotine as the
sole carbon and nitrogen source (Figure 4), both mutants were
able to grow on ISM supplemented with 1 g/L (NH4)2SO4
and 1 g/L glucose as the nitrogen and carbon sources,
respectively. Furthermore, following complementation of
the corresponding gene, each mutant displayed restored
FIGURE 1 | Genetic organization of clusters ndrA1A2A3 and
ndrB1B2B3B4 in Sphingomonas melonis TY and amino acid sequence
identity with related genes (A). Arrows indicate the size and direction of
transcription of each gene. vppAs, nicotine hydroxylase, subunit S; vppAL,
nicotine hydroxylase, subunit L; ndhM, nicotine dehydrogenase, subunit M;
ndhS, nicotine dehydrogenase, subunit S; ndhL, nicotine dehydrogenase,
subunit L. TY, Sphingomonas melonis TY; SJY1, Ochrobactrum sp. SJY1;
pAO1, A. nicotinovorans pAO1; JS614, Nocardioides sp. JS614; B4,
Rhodococcus opacus B4. (B) Comparison of amino acid sequences; the
percentage shows the amino acid identity.
capacity to grow on nicotine, similar to wild-type TY
(Figure 4).
Based on the results of gene knockout and complementation,
it appears that ndrA1 and ndrB2 are involved in the capability of
strain TY to utilize nicotine as a sole carbon and nitrogen source,
suggesting that one of these two sets of gene clusters encodes
a nicotine dehydrogenase. To further confirm the function of
ndrA1A2A3 and ndrB1B2B3B4, we performed a nicotine and
6 HN biotransformation test using the wild-type TY strain,
the mutant strains and strains complemented with the two
genes. Although TY1ndrA1 and TY1ndrB2 lost the ability to
degrade and transform nicotine, they retained 6 HN conversion
capacity (Figure 4). Complementation of the corresponding gene
restored the ability of both TY1ndrA1(pRK415-ndrA1) and
TY1ndrB2(pRK415-ndrB2) to degrade and transform nicotine.
Because TY1ndrA1 and TY1ndrB2 can grow on ISM
medium supplemented with 6 HN as the sole carbon
and nitrogen source (Figure 5), combined with the
biotransformation results, it appears that the two mutant
strains not only retain the ability to transform 6 HN but can also
degrade it completely. This result indicates that disruption of
ndrA1 or ndrB2 only affects the first step in nicotine metabolism,
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supporting our speculation that a nicotine dehydrogenase is
encoded by one of these two sets of genes.
No Catalytic Activity was Detected after
Heterologous Expression of NdrA1A2A3
and NdrB1B2B3B4
To shed light on the function of these two gene clusters, we tested
the nicotine-degrading activity of ndrA1A2A3 and ndrB1B2B3B4
through heterologous expression in P. putida KT2440 and S.
aquatilis; the latter was selected because it is a member of
FIGURE 2 | Changes in transcriptional levels of genes putatively
involved in nicotine degradation. RT-qPCR analysis of target gene
transcripts produced in Sphingomonas melonis TY grown with or without
nicotine. The results presented in these histograms are the means of three
independent experiments, and error bars indicate the standard error.
the same genus as strain TY but does not exhibit nicotine
degradation ability. However, neither whole cell nor crude cell
extracts exhibited nicotine dehydrogenase activity.
The cofactor molybdopterin cytosine dinucleotide (MCD)
is needed for Ndh nicotine dehydrogenase function in
A. nicotinovorans pAO1 (Sachelaru et al., 2006; Ganas and
Brandsch, 2009), we thought MCD or other cofactor is needed
by the putative nicotine dehydrogenase in strain TY. Thus,
we identified two genes, orf1 and orf2, contiguous on the
genome with ndrB1B2B3B4 that show similarity with coxF and
mobA (involved in MCD biosynthesis in A. nicotinovorans
pAO1), and orf2 shows LAAG amino acid motif as the
canonical MocA (Neumann et al., 2011). We cloned these
six genes into pRK415 for expression in E. coli DH5α,
S. aquatilis and P. putida KT2440 and into pET-28a(+) for
expression in E. coli BL21(DE3). However, whole cell and crude
cell extracts showed no nicotine dehydrogenase activity. In
addition, SDS-PAGE was carried out on extracts from E. coli
BL21(DE3)pET28a-ndrB1B2B3B4orf1orf2 and its control strain
E. coli BL21(DE3)pET28a, and several bands were appeared in
the former compared to the latter (data not shown).
DISCUSSION
S. melonis TY can degrade nicotine efficiently than many other
nicotine degraders, and has tolerance to some neonicotinoid
insecticides when degrading nicotine, which is suitable for the
disposal of tobacco waste and the reduction of nicotine in tobacco
leaves and this tolerance was not reported in other nicotine
degraders (Wang et al., 2011). In this study, we identified two
sets of genes involved in the nicotine metabolism in S. melonis
TY. Both mutants were able to grow on glucose and (NH4)2SO4,
indicating that disruption of ndrA1 and ndrB2 did not affect basic
metabolism. Moreover, following gene complementation, both
FIGURE 3 | PCR verification of TY1ndrA1 and TY1ndrB2 using specific primers beyond the homologous fragments and primers in the resistance
gene. (A) Sample 1, amplified with ndrA1-VF and Kan02, 2260 bp; sample 2, amplified with ndrA1-VR and Kan01, 2172 bp; sample 3, amplified with ndrB2-VF and
Kan01, 2308 bp; sample 4, amplified with ndrB2-VR and Kan02, 2330 bp; M1, DL15000 marker; M2, DL2000 marker. Electrophoresis was performed using 0.8%
agarose; (B) The in-frame deletion of target genes, and relative site of genomic-specific primers and resistance gene-specific primers.
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FIGURE 4 | Growth ability of strain TY and its derivatives with nicotine and their biotransformation ability with nicotine and 6-hydroxynicotine.
(A) Growth ability of wild-type TY (1), TY1ndrA1 (2), TY1ndrB2 (3), TY1ndrA1(pRK415-ndrA1) (4), and TY1ndrB2(pRK415-ndrB2) (5); (B) Biotransformation of
nicotine by wild-type TY and two complementary strains, and example is shown because they are similar spectrometric graphs; (C) Biotransformation of
6-hydroxynicotine by wild-type TY, two mutant strains and two complementary strains, example is shown because they are similar spectrometric graphs.
complemented strains regained the ability to utilize nicotine.
The gene knockout and complementation results indicated that
ndrA1 and ndrB2 may be involved in converting nicotine to 6
HN, the first step in the VPP pathway.
To elucidate the function of these two gene clusters, we
tested the nicotine-degrading activity of ndrA1A2A3 and
ndrB1B2B3B4. Many gene products show activity when
heterologously expressed in E. coli DH5α and P. putida
KT2440, such as the nicotine hydroxylation vppA gene from
Ochrobactrum sp. strain SJY1 (Yu et al., 2015), the 6 HN
oxidation 6 hlno gene from A. nicotinovorans pAO1 (Ganas and
Brandsch, 2009), and the nicotine oxidoreduction nicA gene
from P. putida S16. Furthermore, homologous expression is an
effective approach for successful protein expression, for example,
6 hlno and ndhMSLcoxFmobA (for nicotine oxidoreduction)
(Ganas and Brandsch, 2009) and ndhL and kdhL (for 6 HPON
dehydrogenation) (Sachelaru et al., 2006). However, expression
of ndrA1A2A3 and ndrB1B2B3B4 in P. putida KT2440 and
S. aquatilis did not confer activity on a heterologous host.
Based on nicotine-related research of well-established A.
nicotinovorans, we speculate that the nicotine dehydrogenase
in strain TY might require a cofactor, such as MCD in A.
nicotinovorans (Sachelaru et al., 2006). Surprisingly, we found
two genes showing similarity tomobA and coxF contiguous with
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FIGURE 5 | Growth of TY1ndrA1 and TY1ndrB2 in ISM supplemented
with 6-hydroxynicotine as a substrate. (A), TY1ndrA1; (B), TY1ndrB2;
(C), wild-type TY.
ndrB1B2B3B4 on the strain TY genome. We cloned these two
genes, orf1 and orf2, together with ndrB1B2B3B4 into vectors
pRK415 and pET-28a(+) and transformed the plasmids into E.
coliDH5α, S. aquatilis, P. putida KT2440, and E. coli BL21(DE3).
However, no nicotine dehydrogenase activity was detected.
Indeed, heterologous expression with a constitutive or inducible
promoter showed that ndrA1A2A3 and ndrB1B2B3B4 alone
cannot confer nicotine dehydrogenase activity. Considering
that TY1ndrA1 and TY1ndrB2 retained the ability to degrade
6 HN and that ndrA1A2A3 and ndrB1B2B3B4 alone could
not confer nicotine dehydrogenase activity, we propose that
ndrA1A2A3, and ndrB1B2B3B4 are involved and necessary for
nicotine dehydrogenase in strain TY but require additional
factors. Additionally, disruption of ndrA1 or ndrB2 resulted in
no nicotine dehydrogenase activity.
There are possible two speculations for the reasons why
the expression of the ndrA1A2A3 and ndrB1B2B3B4 in the
tested strains failed. First, the tested strains did not provide
a suitable environmental for the transcription, translation or
protein folding of the introduced gene sets, such as the different
codon usage bias between the gene sets in strain TY and the tested
strains and any incorrect step in the formation of functional
protein. These errors will lead to the negative results. Second,
these two gene sets may take no part in catalyzing the initial
degradation of nicotine but perform other essential function
in nicotine degradation in strain TY. However, we think that
influence of uptake of nicotine by the tested strains can be
excluded because both whole cell and crude cell extracts reactions
were performed to exhibit activities, and P. putida KT2440 were
reported to express functional vppA (Yu et al., 2015).
In studying related genes involved in certain pathway or
cellular network, there are several approaches for generating
mutants. Nonetheless, some mutants obtained are in genes
that do not actually function in the studied pathway due to
the influence of gene organization, such as polar effects on
downstream genes. However, ndrA1A2A3 and ndrB1B2B3B4 are
not contiguous in the strain TY genome, and there are no other
nearby putative genes related to nicotine degradation. Knockout
of ndrA1 and ndrB2 led to the same superficial phenotypic
effect on the undefined nicotine dehydrogenase in strain TY,
which was presumably not due to potential downstream effects.
Generally, we thought the function of both clusters ndrA1A2A3
and ndrB1B2B3B4 is essential for nicotine degradation in
strain TY.
In a word, current experimental data only support that
ndrA1A2A3 and ndrB1B2B3B4 are essential in nicotine
degradation in strain TY, and the relationship between them
is unclear. We have proposed three hypotheses about the
relationship between these two gene sets. First, because the
details of the reaction mechanism of nicotine conversion to
6 HN are not available and it is classified as different type of
reaction according to the source of oxygen in hydroxylation
(Hirschberg and Ensign, 1971), and the enzyme is considered
as hydroxylase or oxygenase accordingly.. Moreover, reports
have speculated some similar mechanisms in nicotinic acid
and nicotine degradation (Tang et al., 2012). A previous study
showed that 6-hydroxynicotinic acid is formed during nicotinic
acid degradation; moreover, the oxygen incorporated into 6-
hydroxynicotine acid was from water and not oxygen gas (Hunt
et al., 1958; Hirschberg and Ensign, 1971). It was proposed that
a dihydro-monohydroxy derivative of nicotinic acid was formed
during nicotinic acid degradation, though no such derivative was
identified (Hunt et al., 1958). Combining the similarity of the
pyridine ring structure and the similar hydroxylation reaction of
the pyridine ring in nicotinic acid and nicotine, we speculate that
the same molecular mechanism of hydroxylation occurs with
nicotine to generate 6 HN, as it does with nicotinic acid. If a type
of dihydro-monohydroxy derivative of nicotine is generated,
then ndrA1A2A3 and ndrB1B2B3B4 may play essential roles in
converting nicotine to its dihydro-monohydroxy derivative and
then to 6 HN. Second, one of the two sets of gene is directly
related with nicotine degradation and need specific cofactor, and
the other one is indirectly related. Third, neither of the two sets
of genes is direct related with nicotine degradation, and there is
an undefined real nicotine dehydrogenase in strain TY. However,
this kind of undirected related function is unknown and need
further study.
In summary, this study provides evidence indicating that
two novel sets of genes in S. melonis TY are crucial for
nicotine degradation. These two sets of genes are first reported
here as being involved in the variant of the pyridine and
pyrrolidine pathway of nicotine degradation and show similarity
with isoenzymes in other nicotine-degrading microbes, an
unexpected and surprising result. It will be important to
determine whether ndrA1A2A3 and ndrB1B2B3B4 are both
involved and/or function together in nicotine dehydrogenase
activity as well as what type of reactions are involved in the
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still-undefined nicotine dehydrogenase in strain TY. Although
uncertainty remains regarding the exact function of these two
gene clusters, further research is in progress to characterize their
function(s). These findings will provide a deeper understanding
of the molecular mechanisms of nicotine metabolism in
Sphingomonas.
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